As the cannabis industry continues its steady growth, one public exchange in Canada has seen a momentum increase in its stocks thanks to favorable policy in the US.

Barrington Miller, director of listed company services for the Canadian Securities Exchange (CSE) credited the approach by the exchange to allow the listing of non licensed producer (LP) cannabis ventures early on the rush for these stocks, he told the Investing News Network (INN).


On Monday (May 28) the exchange hosted a conversation with investors on the cannabis listed companies offering exposure into various markets across the US and Canada on the CSE.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

The event included presentations from companies such as Quinsam Capital (CSE:QCA), QuadronCorp (CSE:QCC), and a presentation showcasing an event about upcoming public companies like Ascent Industries, a venture holding licenses to grow cannabis in Canada and the states of Nevada and Oregon.

The CSE was able to share to investors the growth some of its listed cannabis stocks have done such as MPX Bioceutical (CSE:MPX), CannaRoyalty (CSE:CRZ), Beleave (CSE:BE), TerrAscend (CSE:TER) and Liberty Health Sciences (CSE:LHS).

Miller told INN thanks to the positive outlook the US political landscape currently holds for cannabis–despite the drug remaining illegal at a federal level–has impacted the volume of listings on the CSE.

“It seems that the government is addressing the issue and they realize this is not going to be going away and quite frankly there’s a lot of revenue to be made from it and a lot of job opportunities and most importantly quality of life and health and wellness,” he said.

Outlook on US focused CSE listed companies has turned around

During the Lift & Co Expo in Toronto this past weekend, Miller was part of an investing panel where his fellow panelists expressed a bullish sentiment for these CSE stocks, despite earlier in the year opinions were more bearish due to the risks.

John Medland, partner with Blair Franklin Capital Partners said in January he saw more opportunity with CSE US-focused stocks than most experts gave credit to. When asked later by INN why he expressed the risk with these stocks at the time was overblown, he said his expectation was that no crackdowns were coming for these ventures in the US.

“When you look at all those factors I think the American administration is sending some positive signals that the market is reaction to and of course we are feeling it up here in Canada as well,” Miller said.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

New partnerships across exchanges are beneficial for everyone, says CSE official

Over the weekend of May 26-27, MedMen, a popular cannabis operator in California, confirmed its public launch on the CSE market. MedMen has clear intentions in the Canadian market as it developed a partnership with Cronos Group (NASDAQ:CRON; TSX:CRON).

The combined venture will be called MedMen Canada and will focus on the development of branded products and manage retail stores in the country.

CannaRoyalty, also a US operator, inked a deal with National Access Cannabis (TSXV:META) to bring its brands into the planned retail stores the Canadian focused venture will operate once the recreational market comes online across Canada.

On the issue of these new partnerships across Canadian exchanges Miller told INN there are enough opportunities to go around for everyone in the four Canadian public markets.

“If a company is doing business with another company on another exchange that benefits both exchanges,” Miller said.

Pot stocks in Canada have provided boosts to the performance of the major exchanges thanks to the trading activity these see on a regular basis. The CSE Index 25, which tracks the largest companies in the exchange, is regularly topped by the various cannabis listings available to shareholders.

Be sure to check back with @INN_Cannabis for our video interviews and panel recaps from the the Lift & Co. Expo

Don’t forget to follow us @INN_Cannabis for real-time news updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: Beleave is a client of the Investing News Network. This article is not paid for content.

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 

Two US-based multi-state operators (MSOs) added fuel to the ongoing merger and acquisition (M&A) train currently making its way across the cannabis sector.

On the flip side, one of Canada’s biggest cannabis producers told the market this week that it has no interest in further acquisitions in the Canadian market.

Keep reading... Show less

 Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) (“Better Plant”) or (the “Company”), a wellness company that makes and sells plant-based products, is ramping up production at its Victoria, BC production facility to fulfill incoming orders from seven Whole Foods Market in Ontario, Canada (“Whole Foods”).

Cannot view this image? Visit: https://orders.newsfilecorp.com/files/6377/84022_947985ee845d7afb_001.jpg

Keep reading... Show less
  • Domestic Medical Net Revenue Steady at $26.9 Million
  • Strong International Medical Net Revenue of $9.4 Million
  • Total Cannabis Net Revenue, Excluding Provisions, of $58.4 Million
  • Business Transformation Plan Continues, Management Expects to Deliver Incremental Cost-Saving Measures of $60 Million to $80 Million Annually
  • Balance Sheet Remains Strong with ~$525 Million of Cash on Hand at May 12, 2021
  • Lead Independent Director Ronald Funk Appointed as Chairman, Michael Singer to Remain Board Member

NYSE | TSX: ACB

 Aurora Cannabis Inc. (the ” Company ” or ” Aurora “) (NYSE: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, today announced its financial and operational results for the third quarter of fiscal 2021 ended March 31, 2021 .

Keep reading... Show less

Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies

Keep reading... Show less

Experienced executives fill senior roles in business development, M&A, clinic operations and design, and corporate communications

Numinus Wellness Inc. (“Numinus” or the “Company”) (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced the appointments of five experienced leaders to support strategic growth initiatives across the Company’s three divisions Numinus Health, Numinus R&D and Numinus Bioscience.

Keep reading... Show less